Sellas Life Sciences Group Inc (NASDAQ:SLS)
| 1.74 BATS BZX Real-Time Price As of 2:35pm ET |  -0.09 / -4.92%Today’s Change | 1.17 Today|||52-Week Range 5.58 | -26.27% Year-to-Date |
Latest SLS News | Press Releases
No recent news for Sellas Life Sciences Group Inc.
Today’s Trading
| Previous close | 1.83 |
| Today’s open | 1.77 |
| Day’s range | 1.74 - 1.78 |
| Volume | 503 |
| Average volume (3 months) | 132,859 |
| Market cap | $42.8M |
Data as of 2:35pm ET, 09/28/2023
Growth & Valuation
| Earnings growth (last year) | -59.27% |
| Earnings growth (this year) | +46.83% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -86.84% |
| P/E ratio | NM |
| Price/Sales | 45.77 |
| Price/Book | 6.80 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NERVMinerva Neuroscience... | 0.00 | 0.00% |
| THTXTheratechnologies In... | +0.08 | +3.76% |
| HOOKHOOKIPA Pharma Inc | -0.01 | -2.00% |
| SLGLSol Gel Technologies... | 0.00 | 0.00% |
Data as of 2:38pm ET, 09/28/2023
Financials
| Next reporting date | November 16, 2023 |
| EPS forecast (this quarter) | $0.01 |
| Annual revenue (last year) | $1.0M |
| Annual profit (last year) | -$41.3M |
| Net profit margin | -4,130.10% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
